CD163 and Stroke: Hypothesized by authors to be a driving component in the termination of inflammation and possible reduction in autoimmune damage, sCD163 was studied in a group of 39 patients who had suffered an ischemic stroke compared to 20 controls and 20 stroke mimics [98].